Consensus McKesson Corporation

Stocks

MCK

US58155Q1031

Pharmaceuticals

Market Closed - NYSE 02:30:02 10/11/2026 am IST			5-day change	1st Jan Change
1,059.37 ^USD	-0.14%		+6.11%	+29.15%

09/11	Surgery Partners Agrees to Improved $6 Billion Buyout Deal by HealthSpan Partners	MT
06/11	Mckesson Insider Sold Shares Worth $716,924, According to a Recent SEC Filing	MT

Evolution of the Average Target: McKesson Corporation

Evolution of the Target Price: McKesson Corporation

Changes in Analyst Recommendations: McKesson Corporation

b044c8aea.qLsEVdxLe5BBrpLNi1B6xU1fd-MD3XENoAkutUOVD5s.kNleOrMnOqI4wcqa7iUDqCdmD6ZiiTJL51185Hf_aars6jcbuA0B5irE2w~a892269ed974656bb624334a70b448cc

Analysts' recommendations: McKesson Corporation

05/11	Deutsche Bank Adjusts McKesson Price Target to $1,120 From $913	MT
05/11	McKesson Continues 'Impressive' Execution, RBC Says	MT
05/11	UBS Adjusts Price Target on McKesson to $1,250 From $1,200, Maintains Buy Rating	MT
05/11	RBC Raises Price Target on McKesson to $965 From $845, Keeps Sector Perform Rating	MT
05/11	Mizuho Adjusts Price Target on McKesson to $1,050 From $1,020	MT
05/11	Leerink Partners Adjusts Price Target on McKesson to $1,200 From $1,070	MT
05/11	Baird Adjusts Price Target on McKesson to $1,225 From $1,017	MT
05/11	Evercore ISI Adjusts Price Target on McKesson to $1,200 From $1,000	MT
05/11	TD Cowen Adjusts Price Target on McKesson to $1,200 From $1,006	MT
05/11	Nasdaq Tumbles as Wall Street Picks Its Winners and Losers
05/11	Analyst recommendations: Block, Cisco System, Fair Isaac, Skyworks, Duolingo…
20/10	Mizuho Adjusts Price Target on McKesson to $1,020 From $905	MT
16/10	UBS Adjusts McKesson Price Target to $1,200 From $1,080, Maintains Buy Rating	MT
12/10	Baird Adjusts Price Target on McKesson to $1,017 From $1,015	MT
07/10	Leerink Partners Adjusts Price Target on McKesson to $1,070 From $1,030	MT
07/10	Truist Downgrades Option Care Health to Buy From Hold on Heels of Announced Sale to McKesson, CD&R; Adjusts PT to $32.05 From $30	MT
14/09	McKesson Continues to Face Medium-Term Headwinds From Declining Employer Coverage of GLP-1, RBC Says	MT
03/09	Argus Adjusts Price Target on McKesson to $970 From $850, Maintains Buy Rating	MT
19/08	McKesson's Specialty Drug Mix Helps Cushion Pricing Pressure, RBC Says	MT
19/08	RBC Initiates McKesson at Sector Perform With $845 Price Target	MT
18/08	Barclays Raises Price Target on McKesson to $1,000 From $925, Maintains Overweight Rating	MT
11/08	Wells Fargo Adjusts Price Target on McKesson to $933 From $812, Maintains Equalweight Rating	MT
06/08	Mizuho Adjusts Price Target on McKesson to $905 From $885	MT
06/08	TD Cowen Adjusts Price Target on McKesson to $1,006 From $989	MT
06/08	Evercore ISI Adjusts Price Target on McKesson to $1,000 From $860	MT

More recommendations

Pharmaceuticals Wholesale

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	MCKESSON CORPORATION					+6.43%
	ELI LILLY AND COMPANY					+7.34%
	JOHNSON & JOHNSON					+1.15%
	ABBVIE INC.					+6.64%
	ROCHE HOLDING AG					+1.08%
	MERCK & CO., INC.					+10.08%
	NOVARTIS AG					-6.85%
	ASTRAZENECA PLC					+15.51%
	AMGEN INC.					-6.66%
	GILEAD SCIENCES, INC.					+4.72%
	Average					+3.95%
	Weighted average by Cap.					+4.55%